Finding the best linezolid dose for people on dialysis
Treatments studied
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study is testing a way to adjust the dose of an antibiotic called linezolid for people on hemodialysis. The goal is to find the right dose to treat infections safely and effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be on hemodialysis (a treatment that filters your blood).
- You cannot be pregnant or breastfeeding.
- You cannot have advanced liver disease.
- You cannot be taking antidepressants or antipsychotic medications.
- You cannot have a blood disorder like chronic low platelets.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adjusting the dose of linezolid based on regular blood tests can help people with multidrug-resistant tuberculosis (MDR-TB) tolerate the medication better while on the BPaL or BPaL-M regimen. It aims to reduce side effects and improve treatment success.
This study looks at how the body processes oral antibiotics in young babies. It aims to help doctors choose the right doses by studying how these medicines move through the body.
This study checks if measuring the amount of linezolid medicine in your blood helps treat rifampin-resistant tuberculosis more safely and effectively. It is for people who have already started a treatment plan that includes linezolid.
This trial studies how the drug zoledronic acid (used for bone loss) works in people with kidney disease who are on dialysis. It aims to help treat osteoporosis (weak bones) safely in this group.
This study looks at how a common antibiotic is removed by kidney dialysis in very ill patients. This may help doctors give the right amount to keep the infection under control.
This study tests how a single dose of an antiviral medicine called letermovir behaves in people with severe kidney disease, with or without regular haemodialysis. It aims to find the right dose for this population to prevent or treat infections.
Hear when a new Kidney Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.